Last reviewed · How we verify
Analogous Oseltamivir Phosphate Capsules
Oseltamivir Phosphate is a neuraminidase inhibitor, targeting the influenza virus.
Oseltamivir Phosphate is a neuraminidase inhibitor, targeting the influenza virus. Used for Influenza.
At a glance
| Generic name | Analogous Oseltamivir Phosphate Capsules |
|---|---|
| Sponsor | Dalian Zhen-Ao Bio-Tech Co., Ltd. |
| Drug class | Neuraminidase inhibitor |
| Target | Neuraminidase |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | Phase 2 |
Mechanism of action
Oseltamivir Phosphate works by inhibiting the neuraminidase enzyme, preventing the release of the influenza virus from infected cells.
Approved indications
- Influenza
Common side effects
- Nausea
- Vomiting
- Headache
Key clinical trials
- Phase IIaTrials of GanMaoKangNing Granules (PHASE2)
- Lingdancao Granules in the Treatment of Seasonal Influenza (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: